MedPath
NMPA Approval

Peramivir Injection

国药准字H20253769

April 1, 2025

Drug Information

帕拉米韦注射液

注射剂

60ml:0.3g(按C₁₅H₂₈N₄O₄计)

化学药品

April 1, 2025

Company Information

Applicant Company

山东省淄博市临淄区宏达路17号

Manufacturing Company

山东省淄博市临淄区宏达路17号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

帕拉米韦注射液 - NMPA 批准文号 | MedPath